Natural History & Spectrum of Atherosclerosis

Stages of Progression

1. Endothelial Dysfunction (Earliest Change)

• Triggered by risk factors: hyperlipidemia, hypertension, smoking, diabetes, oxidative stress
• Endothelial cells upregulate adhesion molecules (VCAM-1, ICAM-1)
• Increased permeability to LDL particles
• No visible lesion at this stage — purely functional

2. Fatty Streak

• LDL enters the intima and undergoes oxidative modification (ox-LDL)
• Monocytes adhere, migrate into the intima, and differentiate into macrophages
• Macrophages engulf ox-LDL → become foam cells (lipid-laden)
• Fatty streaks are flat, yellow, lipid-rich deposits visible as early as the first decade of life
• Found even in children and teenagers at autopsy
• Potentially reversible at this stage

3. Intermediate Lesion (Gelatinous Plaque)

• Smooth muscle cells migrate from tunica media → intima (driven by PDGF, FGF)
• Extracellular lipid accumulates alongside intracellular foam cells
• Early fibrous tissue deposition begins

4. Fibrous Plaque (Atheroma)

• A fibrous cap forms over a lipid-rich necrotic core
• Cap composed of smooth muscle cells, collagen, and proteoglycans
• Plaque enlarges and begins to encroach on the lumen
• Clinically silent — does not cause symptoms until lumen narrows >70%
• Stable angina may appear at this stage

5. Complicated Plaque

Progression of atherosclerosis: stages from initial lesion → fibrous cap atheroma → thin fibrous cap (vulnerable) → calcified plaque → rupture with thrombosis. Also illustrates intimal vs. medial (Mönckeberg) calcification patterns.

AHA Lesion Classification (Stary Classification)

Temporal Spectrum: Birth to Clinical Event

Childhood       Adolescence       20s–40s          40s–60s+
    |                |                |                 |
Fatty streak → Fibrous plaque → Complicated → Clinical Event
(asymptomatic)   (asymptomatic)    plaque        (ACS, stroke,
                                (silent or       PAD, aneurysm)
                                angina)

• Childhood: Fatty streaks in aorta
• Adolescence/Young adulthood: Fatty streaks in coronary arteries (found in trauma autopsies of soldiers in Korea and Vietnam wars)
• Middle age: Raised fibrous plaques; coronary artery disease may become symptomatic
• Advanced age: Complicated plaques with calcification, stenosis, thrombosis

Clinical Manifestations by Vascular Territory

Key Concepts in Natural History

Vulnerable Plaque vs. Vulnerable Patient

• A vulnerable (high-risk) plaque has: thin fibrous cap (<65 µm), large lipid core (>40% of plaque volume), intraplaque inflammation, positive remodeling
• A vulnerable patient has: multiple vulnerable plaques, systemic inflammation, hypercoagulable state
• Most ACS events arise from non-flow-limiting plaques (<50% stenosis) — this is why angiography alone underestimates risk

Plaque Regression

• Aggressive LDL lowering (statins, PCSK9 inhibitors) can induce plaque regression — reduction in noncalcified plaque volume
• Coronary CT Angiography (CCTA) studies show: in patients with LDL reduction >10%, regression of all noncalcified plaque components occurs; without LDL reduction, progression occurs across all components (Coronary CT Imaging of Atherosclerotic Plaque, p. 11)
• Plaque progression by serial CCTA is an independent predictor of ACS (HR: 33.4), with events in 14.3% of progressors vs. 0.3% of non-progressors (Coronary CT Imaging, p. 11)

Rate of Progression

• Annualized increase in total coronary plaque volume: ~50 mm³/year in diabetics vs. ~21 mm³/year in non-diabetics
• Noncalcified plaque grows far faster in diabetics (~31 mm³/year) vs. non-diabetics (~2.5 mm³/year) (Coronary CT Imaging, p. 11)

Response-to-Injury Hypothesis (Ross)

Risk Factor Influence on Natural History

Summary